Niklason Laura E 13D/13G Filings for Humacyte, Inc. (HUMA)

Niklason Laura E 13D and 13G filings for Humacyte, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-20
7:10 pm
Sale
2024-11-1813DHUMACYTE INC
HUMA
Niklason Laura E6,007,745
4.600%
-1,697,728decrease
(-22.03%)
Filing
2024-09-03
4:11 pm
Sale
2024-08-2913DHUMACYTE INC
HUMA
Niklason Laura E7,705,473
6.300%
-1,481,428decrease
(-16.13%)
Filing
2024-06-04
7:00 pm
Sale
2024-05-3113DHUMACYTE INC
HUMA
Niklason Laura E9,186,901
7.600%
-966,294decrease
(-9.52%)
Filing
2024-03-08
4:03 pm
Purchase
2024-03-0513DHUMACYTE INC
HUMA
Niklason Laura E10,153,195
8.400%
102,373increase
(+1.02%)
Filing
2023-09-15
4:09 pm
Sale
2023-09-1413DHUMACYTE INC
HUMA
Niklason Laura E10,050,822
9.500%
-1,561,987decrease
(-13.45%)
Filing
2023-08-21
6:19 pm
Sale
2023-08-1713DHUMACYTE INC
HUMA
Niklason Laura E11,612,809
11.100%
-2,298,579decrease
(-16.52%)
Filing
2023-05-26
5:05 pm
Sale
2023-05-2513DHUMACYTE INC
HUMA
Niklason Laura E18,786,211
17.900%
-3,550,200decrease
(-15.89%)
Filing
2021-08-27
9:14 pm
Purchase
2021-08-2613DHUMACYTE INC
HUMA
Niklason Laura E23,268,279
22.400%
23,268,279increase
(New Position)
Filing